For patients with seizures, there’s a real difference between ordering exome sequencing first and starting with a multi-gene panel or chromosomal microarray (CMA).
Findings from the first 4,000 newborns screened using GeneDx genome sequencing, were published today in the Journal of the American Medical Association (JAMA).